AlphaCrest Capital Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,721
Closed -$2.4M 231
2022
Q3
$2.4M Sell
18,721
-23,265
-55% -$3.36M 0.15% 166
2022
Q2
$5.92M Buy
41,986
+20,868
+99% +$2.98M 0.29% 48
2022
Q1
$2.94M Sell
21,118
-28,232
-57% -$4.33M 0.16% 129
2021
Q4
$8.61M Buy
49,350
+29,909
+154% +$4.99M 0.32% 40
2021
Q3
$3.22M Sell
19,441
-40,393
-68% -$6.96M 0.17% 141
2021
Q2
$10.8M Buy
59,834
+15,179
+34% +$2.77M 0.46% 13
2021
Q1
$8.61M Buy
44,655
+21,402
+92% +$4.12M 0.48% 23
2020
Q4
$4.7M Buy
23,253
+9,423
+68% +$1.95M 0.39% 39
2020
Q3
$2.91M Buy
+13,830
New +$3.08M 0.32% 41
2020
Q2
Sell
-10,580
Closed -$1.83M 933
2020
Q1
$1.83M Sell
10,580
-5,087
-32% -$840K 0.22% 92
2019
Q4
$2.41M Sell
15,667
-43,228
-73% -$6.46M 0.2% 87
2019
Q3
$8.94M Buy
58,895
+48,649
+475% +$7.69M 0.54% 5
2019
Q2
$1.57M Buy
10,246
+3,273
+47% +$500K 0.14% 223
2019
Q1
$1.12M Buy
+6,973
New +$1.08M 0.17% 147

Other funds holding CLX

AlphaCrest Capital Management's CLX Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Clorox (CLX) in Q4 2022, closing a stake of 18,721 shares — an estimated $2.4M sold.

AlphaCrest Capital Management first reported a position in CLX in Q1 2019 and held it in 14 quarters. The position peaked at $10.8M in Q2 2021. 1,107 funds tracked by Wall St. Rank hold CLX as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Clorox position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 18,721 Clorox shares in Q4 2022, an estimated $2.4M.
  • AlphaCrest Capital Management first reported a position in Clorox in Q1 2019 and held it in 14 quarters.
  • AlphaCrest Capital Management's Clorox position peaked at $10.8M in Q2 2021.
  • 1,107 funds tracked by Wall St. Rank held Clorox as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.